{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:23:28Z","timestamp":1762835008011,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005790","name":"Thammasat University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["45\/2561","NRCT 820\/2563"],"award-info":[{"award-number":["45\/2561","NRCT 820\/2563"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Modelling"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.idm.2023.05.013","type":"journal-article","created":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T17:37:11Z","timestamp":1685900231000},"page":"783-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Simulation of optimal dose regimens of photoactivated curcumin for antimicrobial resistance pneumonia in COVID-19 patients: A modeling approach"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9034-7769","authenticated-orcid":false,"given":"Teerachat","family":"Saeheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6389-0897","authenticated-orcid":false,"given":"Kesara","family":"Na-Bangchang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idm.2023.05.013_bib1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1186\/s12879-021-06616-4","article-title":"Clinical outcomes in patients co-infected with COVID-19 and Staphylococcus aureus: A scoping review","volume":"21","author":"Adalbert","year":"2021","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.idm.2023.05.013_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejpb.2021.01.012","article-title":"Antimicrobial and antibiofilm photodynamic therapy against vancomycin resistant Staphylococcus aureus (VRSA) induced infection in\u00a0vitro and in\u00a0vivo","volume":"160","author":"Akhtar","year":"2021","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.idm.2023.05.013_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/jac\/dkm242","article-title":"Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg\/kg of iclaprim (AR-100) in healthy men","volume":"60","author":"Andrews","year":"2007","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.idm.2023.05.013_bib4","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/00002030-200307250-00022","article-title":"Detection of intrapulmonary concentration of lopinavir in the HIV-infected patient","volume":"17","author":"Atzori","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.idm.2023.05.013_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/jac\/dkg457","article-title":"Antibacterial susceptibility of vancomycin-resistant Staphylococcus aureus strain isolated at Hershey Medical Center","volume":"52","author":"Bozdogan","year":"2003","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.idm.2023.05.013_bib7","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1128\/AAC.01468-05","article-title":"Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis","volume":"50","author":"Buerger","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.idm.2023.05.013_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cpdd.695","article-title":"Dalbavancin population pharmacokinetic modeling and target attainment analysis","volume":"9","author":"Carrothers","year":"2020","journal-title":"Clinical Pharmacology in Drug Development"},{"key":"10.1016\/j.idm.2023.05.013_bib9","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or premalignant lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"Anticancer Research"},{"key":"10.1016\/j.idm.2023.05.013_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/380799","article-title":"Once-daily versus twice-daily lopinavir\/ritonavir in antiretroviral-na\u00efve-HIV-positive patients: A 48-week randomized clinical trial","volume":"189","author":"Eron","year":"2004","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.idm.2023.05.013_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01135-17","article-title":"Comparison of omadacycline and tigecycline pharmacokinetics in the plasma, epithelial lining fluid, and alveolar cells of healthy adult subjects","volume":"61","author":"Gotfried","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.idm.2023.05.013_bib12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/jac\/dkg262","article-title":"Intrapulmonary penetration of linezolid","volume":"51","author":"Honeybourne","year":"2003","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.idm.2023.05.013_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3948626","article-title":"In\u00a0vitro activity of iclaprim against methicillin-resistant Staphylococcus aureus nonsusceptible to daptomycin, linezolid, or vancomycin: A pilot study","volume":"2017","author":"Huang","year":"2017","journal-title":"The Canadian Journal of Infectious Diseases & Medical Microbiology"},{"key":"10.1016\/j.idm.2023.05.013_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1745-6215-15-233","article-title":"Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: Study protocol for a phase IIB randomized controlled trial","volume":"15","author":"Kalimuddin","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.idm.2023.05.013_bib15","series-title":"European congress of clinical microbiology and infectious disease (ESCMID)","article-title":"Antimicrobial activity of photo-activated curcumin against planktonic and biofilm microorganisms determined by microcalorimetry","author":"Maiolo","year":"2016"},{"key":"10.1016\/j.idm.2023.05.013_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01663-18","article-title":"High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy","volume":"62","author":"Morroni","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"10","key":"10.1016\/j.idm.2023.05.013_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2165\/00003088-200342100-00002","article-title":"Whole body pharmacokinetic models","volume":"42","author":"Nestorov","year":"2003","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.idm.2023.05.013_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/759138","article-title":"Duration of antimicrobial therapy in community acquired pneumonia: Less is more","volume":"2014","author":"Pinzone","year":"2014","journal-title":"The Scientific World Journal"},{"key":"10.1016\/j.idm.2023.05.013_bib19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1017\/ice.2020.440","article-title":"Prevalence of methicillin-resistant (MRSA) in respiratory cultures and diagnostic performance of the MRSA nasal polymerase chain reaction (PCR) in patients hospitalized with coronavirus 2019 (COVID-19) pneumonia","volume":"42","author":"Punjabi","year":"2021","journal-title":"Infection Control & Hospital Epidemiology"},{"key":"10.1016\/j.idm.2023.05.013_bib20","first-page":"391","article-title":"Pharmacokinetic studies of rifampicin in healthy volunteers and tuberculosis patients","volume":"12","author":"Rafiq","year":"2010","journal-title":"International Journal of Agriculture and Biology"},{"key":"10.1016\/j.idm.2023.05.013_bib21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40262-014-0227-1","article-title":"Physiologically based pharmacokinetic modelling to inform development of intramuscular long-acting nanoformulations for HIV","volume":"54","author":"Rajoli","year":"2015","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.idm.2023.05.013_bib22","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/pharmaceutics11110578","article-title":"Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting rifampicin exposure in tuberculosis and cirrhosis populations","volume":"11","author":"Rasool","year":"2019","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.idm.2023.05.013_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/cpt.2198","article-title":"Model-informed drug development for anti-infectives: State of the art and future","volume":"109","author":"Rayner","year":"2021","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.idm.2023.05.013_bib24","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/cpt.1955","article-title":"Impact of disease on plasma and lung exposure of chloroquine, hydroxychloroquine and azithromycin: Application of PBPK modeling","volume":"108","author":"Rowland-Yeo","year":"2020","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.idm.2023.05.013_bib25","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00228-018-2513-6","article-title":"Utility of physiologically based pharmacokinetic (PBPK) modelling in oncology drug development and its accuracy: A systematic review","volume":"74","author":"Saeheng","year":"2018","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.idm.2023.05.013_bib26","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/cpt.1721","article-title":"Physiologically based pharmacokinetic modelling for optimal dosage prediction of quinine coadministered with ritonavir-boosted lopinavir","volume":"107","author":"Saeheng","year":"2019","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.idm.2023.05.013_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jclinpath-2020-206865","article-title":"Laboratory parameters in patients with COVID-19 on first emergency admission is different in non-survivors: Albumin and lactate dehydrogenase as risk factors","volume":"74","author":"Salinas","year":"2021","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.idm.2023.05.013_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13756-020-00714-9","volume":"9","author":"Shariati","year":"2020","journal-title":"Antimicrobial Resistance and Infection Control"},{"key":"10.1016\/j.idm.2023.05.013_bib29","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance","volume":"10","author":"Sharma","year":"2004","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.idm.2023.05.013_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5414\/CP202076","article-title":"Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans","volume":"53","author":"Storka","year":"2015","journal-title":"International Journal of Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.idm.2023.05.013_bib31","article-title":"Biochemical abnormalities in COVID-19: a comparison of white versus ethnic minority populations in the UK","volume":"19","author":"Taylor","year":"2021","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.idm.2023.05.013_bib32","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1039\/c8pp00584b","article-title":"Evaluation of physicochemical properties and bacterial photoinactivation of phenothiazine photosensitizers","volume":"6","author":"Vara","year":"2019","journal-title":"Photochemical and Photobiological Sciences"},{"key":"10.1016\/j.idm.2023.05.013_bib33","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/cpt.1363","article-title":"Model-informed drug development: Current US regulatory practice and future considerations","volume":"105","author":"Wang","year":"2019","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.idm.2023.05.013_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13756-021-00967-y","article-title":"Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates","volume":"10","author":"Wu","year":"2021","journal-title":"Antimicrobial Resistance and Infection Control"},{"key":"10.1016\/j.idm.2023.05.013_bib35","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.2147\/IDR.S340623","article-title":"In\u00a0vitro activity of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Staphylococcus aureus isolates collected from Chinese hospitals in 2018-2020","volume":"14","author":"Xu","year":"2021","journal-title":"Infection and Drug Resistance"},{"key":"10.1016\/j.idm.2023.05.013_bib36","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.3390\/ijms22073384","article-title":"Airway surface liquid pH regulation in airway epithelium current understandings and gaps in knowledge","volume":"22","author":"Zajac","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.idm.2023.05.013_bib37","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jac\/dkf214","article-title":"Rifampicin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy","volume":"50","author":"Ziglam","year":"2002","journal-title":"Journal of Antimicrobial Chemotherapy"}],"container-title":["Infectious Disease Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468042723000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468042723000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:09:14Z","timestamp":1762834154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468042723000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2468042723000465"],"URL":"https:\/\/doi.org\/10.1016\/j.idm.2023.05.013","relation":{},"ISSN":["2468-0427"],"issn-type":[{"type":"print","value":"2468-0427"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simulation of optimal dose regimens of photoactivated curcumin for antimicrobial resistance pneumonia in COVID-19 patients: A modeling approach","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idm.2023.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}